PCNA and cervical cancer: Additionally, the xenograft model was established to evaluate whether PRDX1 affects the growth of cervical cancer in vivo, and proliferation index and apoptosis index in tumor tissues were assessed by the TdT-mediated dUTP nick end labeling (TUNEL) assay and PCNA immunohistochemical staining.